Skip to content
EntityQ907853· pop 14· linked from 2,023 articles

Also known as L-DOPS, Northera®, SM-5688, (-)-(2S,3R)-2-amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid, (2S,3R)-3,4-dihydroxy-phenylserine, L-Threodops, SM 5688, threo-Dopaserine

Droxidopa, also known as 'L-threo-dihydroxyphenylserine (L-DOPS) and sold under the brand names Northera and Dops' among others, is sympathomimetic medication which is used in the treatment of hypotension (low blood pressure) and for other indications. It is taken by mouth.

~5 min read

Encyclopedic overview

12 sections
Contents
  • Medical uses
  • Side effects
  • Pharmacology
  • Chemistry
  • History
  • Clinical trials
  • Society and culture
  • Names
  • Research
  • See also
  • References
  • External links

Droxidopa, also known as 'L-threo-dihydroxyphenylserine (L-DOPS) and sold under the brand names Northera and Dops' among others, is sympathomimetic medication which is used in the treatment of hypotension (low blood pressure) and for other indications. It is taken by mouth.

Side effects of droxidopa include headache, dizziness, nausea, and hypertension, among others. Droxidopa is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitter norepinephrine (noradrenaline). Hence, it acts as a non-selective agonist of the α- and β-adrenergic receptors. Unlike norepinephrine, but similarly to levodopa (L-DOPA), droxidopa is capable of crossing the protective blood–brain barrier (BBB).

Excerpted from Wikipedia’s “droxidopa” article, available under the CC BY-SA 4.0 licence.